Publication |
Novel benzimidazole-based pseudo-irreversible butyrylcholinesterase inhibitors with neuroprotective activity in an Alzheimer's disease mouse model. Spatz P, Zimmermann T, Steinmüller S, Hofmann J, Maurice T, Decker M. RSC Med Chem. 2022 Jun 20;13(8):944-954. doi: 10.1039/d2md00087c. eCollection 2022 Aug 17.
|
Synthesis and Biological Evaluation of Flavonoid-Cinnamic Acid Amide Hybrids with Distinct Activity against Neurodegeneration in Vitro and in Vivo. Hofmann J, Spatz P, Walther R, Gutmann M, Maurice T, Decker M. Chemistry. 2022 Jul 11;28(39):e202200786. doi: 10.1002/chem.202200786. Epub 2022 May 27.
|
Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase. Gentzsch C, Chen X, Spatz P, Košak U, Knez D, Nose N, Gobec S, Higuchi T, Decker M. Mol Imaging Biol. 2021 Aug;23(4):505-515. doi: 10.1007/s11307-021-01584-2. Epub 2021 Mar 3.
|
Dendritic poly-chelator frameworks for multimeric bioconjugation. Reich D, Wurzer A, Wirtz M, Stiegler V, Spatz P, Pollmann J, Wester HJ, Notni J. Chem Commun (Camb). 2017 Feb 23;53(17):2586-2589. doi: 10.1039/c6cc10169k.
|
|
| Last update Publications 17.09.2022 |
|